Citius Pharmaceuticals (CTXR) Long-Term Debt Issuances (2010 - 2021)

Citius Pharmaceuticals' (CTXR) quarterly Long-Term Debt Issuances came in at $172470.0 in Q2 2021, up 34394.0% on a QoQ basis from $500.0 in Q4 2020.

Citius Pharmaceuticals (CTXR) Long-Term Debt Issuances (2010 - 2021) Analysis & Trends

Citius Pharmaceuticals (CTXR) has 9 years of Long-Term Debt Issuances data on file, last reported at $172470.0 in Q2 2021.

Quarterly Long-Term Debt Issuances changed N/A year-over-year to $172470.0 in Q2 2021, while the trailing twelve-month figure through Sep 2025 was $172470.0 (changed N/A YoY) and the FY2025 annual result came in at $1.3 million, changed N/A from the prior year.
Long-Term Debt Issuances climbed to $172470.0 in Q2 2021, from $500.0 in the prior quarter.
In the past five years, Long-Term Debt Issuances ranged from a high of $2.6 million in Q2 2017 to a low of $500.0 in Q4 2020.
A 3-year average of $712594.0 and a median of $300000.0 in 2017 frame the typical range for Long-Term Debt Issuances.
The widest YoY moves for Long-Term Debt Issuances: up 400.0% in 2017, down 400.0% in 2017.
Tracing CTXR's Long-Term Debt Issuances over 3 years: stood at $300000.0 in 2017, then slumped by 99.83% to $500.0 in 2020, then surged by 34394.0% to $172470.0 in 2021.
The last three Long-Term Debt Issuances figures came in at $172470.0 (Q2 2021), $500.0 (Q4 2020), and $300000.0 (Q3 2017), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Long-Term Debt Issuances (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	-
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	-
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	-
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	-
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	-
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	-
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	-
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	-
10	Citius Pharmaceuticals	15.71 Mn	15.71 Mn	1.00 Mn	-

Download Data